Clinical Trial: An OLIP Study (Open Label Individual Patient) of Nusinersen in a Participant With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838779) titled 'An OLIP Study (Open Label Individual Patient) of Nusinersen in a Participant With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen' on Sept. 10.

Brief Summary: This study is an open label individual patient study of the drug Nusinsersen.

Study Start Date: Sept. 17

Study Type: INTERVENTIONAL

Condition: SMA - Spinal Muscular Atrophy

Intervention: DRUG: Nusinersen Injectable Product

Nusinersen intrathecal injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Information provided by ...